Your browser doesn't support javascript.
loading
A new modeling approach allowing prediction and comparison of the long-term outcomes of treatments for hemophilia B.
Keep, Marjolijn van; Hoxer, Christina Stentoft; Hemstock, Matthew; Groth, Andreas Velsing; Knight, Christopher.
Affiliation
  • Keep MV; BresMed Netherlands BV, Arthur van Schendelstraat 650, 3511MJ Utrecht, The Netherlands.
  • Hoxer CS; Novo Nordisk A/S, Vandtårnsvej 114, DK-2860 Søborg, Denmark.
  • Hemstock M; BresMed Health Solutions, Ltd, North Church House, 84 Queen Street, Sheffield S1 2DW, UK.
  • Groth AV; Novo Nordisk A/S, Vandtårnsvej 114, DK-2860 Søborg, Denmark.
  • Knight C; RTI Health Solutions (Formerly BresMed Health Solutions, Ltd), The Pavilion, Towers Business Park, Wilmslow Road, Didsbury, Manchester M20 2LS, UK.
J Comp Eff Res ; 7(1): 39-48, 2018 01.
Article in En | MEDLINE | ID: mdl-28556675
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Factor IX / Factor X / Hemophilia B Type of study: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Comp Eff Res Year: 2018 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polyethylene Glycols / Factor IX / Factor X / Hemophilia B Type of study: Etiology_studies / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Comp Eff Res Year: 2018 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido